255 related articles for article (PubMed ID: 35638424)
1. The Potential Roles of BCG Vaccine in the Prevention or Treatment of COVID-19.
Wang J; Zhang Q; Wang H; Gong W
Front Biosci (Landmark Ed); 2022 May; 27(5):157. PubMed ID: 35638424
[TBL] [Abstract][Full Text] [Related]
2. BCG Vaccination: A potential tool against COVID-19 and COVID-19-like Black Swan incidents.
Gong W; Mao Y; Li Y; Qi Y
Int Immunopharmacol; 2022 Jul; 108():108870. PubMed ID: 35597119
[TBL] [Abstract][Full Text] [Related]
3. Research progress on specific and non-specific immune effects of BCG and the possibility of BCG protection against COVID-19.
Du J; Su Y; Wang R; Dong E; Cao Y; Zhao W; Gong W
Front Immunol; 2023; 14():1118378. PubMed ID: 36798128
[TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 variants and COVID-19 vaccines: Current challenges and future strategies.
Gong W; Parkkila S; Wu X; Aspatwar A
Int Rev Immunol; 2023; 42(6):393-414. PubMed ID: 35635216
[TBL] [Abstract][Full Text] [Related]
5. Are BCG-induced non-specific effects adequate to provide protection against COVID-19?
Vashishtha VM
Hum Vaccin Immunother; 2021 Jan; 17(1):88-91. PubMed ID: 32762516
[TBL] [Abstract][Full Text] [Related]
6. COVID-19 pandemic: SARS-CoV-2 specific vaccines and challenges, protection via BCG trained immunity, and clinical trials.
Gong W; Aspatwar A; Wang S; Parkkila S; Wu X
Expert Rev Vaccines; 2021 Jul; 20(7):857-880. PubMed ID: 34078215
[No Abstract] [Full Text] [Related]
7. Multiple BCG vaccinations for the prevention of COVID-19 and other infectious diseases in type 1 diabetes.
Faustman DL; Lee A; Hostetter ER; Aristarkhova A; Ng NC; Shpilsky GF; Tran L; Wolfe G; Takahashi H; Dias HF; Braley J; Zheng H; Schoenfeld DA; Kühtreiber WM
Cell Rep Med; 2022 Sep; 3(9):100728. PubMed ID: 36027906
[TBL] [Abstract][Full Text] [Related]
8. Convergence between global BCG vaccination and COVID-19 pandemic.
Islam MZ; Zahan MK; Al-Bari MAA
J Med Virol; 2021 Mar; 93(3):1496-1505. PubMed ID: 32827313
[TBL] [Abstract][Full Text] [Related]
9. The influence of vaccination against tuberculosis with the Bacillus-Calmette-Guérin(BCG) vaccine on COVID-19 incidence and mortality - review of the literature.
Ręka G; Korzeniowska A; Piecewicz-Szczęsna H
Przegl Epidemiol; 2020; 74(2):290-302. PubMed ID: 33115218
[TBL] [Abstract][Full Text] [Related]
10. The BCG Vaccine for COVID-19: First Verdict and Future Directions.
Gonzalez-Perez M; Sanchez-Tarjuelo R; Shor B; Nistal-Villan E; Ochando J
Front Immunol; 2021; 12():632478. PubMed ID: 33763077
[TBL] [Abstract][Full Text] [Related]
11. Potential role of Bacillus Calmette-Guérin (BCG) vaccination in COVID-19 pandemic mortality: Epidemiological and Immunological aspects.
Charoenlap S; Piromsopa K; Charoenlap C
Asian Pac J Allergy Immunol; 2020 Sep; 38(3):150-161. PubMed ID: 32686943
[TBL] [Abstract][Full Text] [Related]
12. Tuberculosis vaccine BCG: the magical effect of the old vaccine in the fight against the COVID-19 pandemic.
Aspatwar A; Gong W; Wang S; Wu X; Parkkila S
Int Rev Immunol; 2022; 41(2):283-296. PubMed ID: 33960271
[TBL] [Abstract][Full Text] [Related]
13. BCG vaccine: Worrying proposal for COVID-19.
Sarinho E; Goudouris E; Solé D
Vaccine; 2021 Jan; 39(3):460-462. PubMed ID: 33341305
[TBL] [Abstract][Full Text] [Related]
14. Non-Specific Effects of Bacillus Calmette-Guérin: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Trunk G; Davidović M; Bohlius J
Vaccines (Basel); 2023 Jan; 11(1):. PubMed ID: 36679966
[TBL] [Abstract][Full Text] [Related]
15. BCG revaccination of health workers in Brazil to improve innate immune responses against COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Junqueira-Kipnis AP; Dos Anjos LRB; Barbosa LCS; da Costa AC; Borges KCM; Cardoso ADRO; Ribeiro KM; Rosa SBA; Souza CC; das Neves RC; Saraiva G; da Silva SM; Silveira EA; Rabahi MF; Conte MB; Kipnis A
Trials; 2020 Oct; 21(1):881. PubMed ID: 33106170
[TBL] [Abstract][Full Text] [Related]
16. Large-Scale Structure-Based Screening of Potential T Cell Cross-Reactivities Involving Peptide-Targets From BCG Vaccine and SARS-CoV-2.
Tarabini RF; Rigo MM; Faustino Fonseca A; Rubin F; Bellé R; Kavraki LE; Ferreto TC; Amaral Antunes D; de Souza APD
Front Immunol; 2021; 12():812176. PubMed ID: 35095907
[TBL] [Abstract][Full Text] [Related]
17. Bacille Calmette Guérin (BCG) and new TB vaccines: Specific, cross-mycobacterial and off-target effects.
Fritschi N; Curtis N; Ritz N
Paediatr Respir Rev; 2020 Nov; 36():57-64. PubMed ID: 32958428
[TBL] [Abstract][Full Text] [Related]
18. Bacillus calmette-guerin as a quick and temporary solution to coronavirus disease-2019.
Kumari P; Gupta UD; Bhagyawant SS
Int J Mycobacteriol; 2021; 10(2):105-110. PubMed ID: 34558459
[TBL] [Abstract][Full Text] [Related]
19. Relationship between Bacillus Calmette Guerin Vaccination Policy and Coronavirus Disease-2019 (COVID-19) Incidence.
Alyasin S; Kanannejad Z; Esmaeilzadeh H; Nabavizadeh H; Ghatee MA; Amin R
Iran J Allergy Asthma Immunol; 2021 Feb; 20(1):106-113. PubMed ID: 33639625
[TBL] [Abstract][Full Text] [Related]
20. Tuberculosis, BCG Vaccination, and COVID-19: Are They Connected?
Borges KCM; da Costa AC; de Souza Barbosa LC; Ribeiro KM; Dos Anjos LRB; Kipnis A; Junqueira-Kipnis AP
Mini Rev Med Chem; 2022; 22(12):1631-1647. PubMed ID: 34983348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
